October 2013
Finding agents that act on the TM—without intolerable side effects—has long been an elusive goal. New drug classes may bring it within reach.
Be sure to check out EyeNet's mobile-optimized digital edition—all the benefits of the print edition, plus digital enhancements. Read on a break at work, kicking back at home with your iPad, or on your phone while in line at the grocery store.